199 related articles for article (PubMed ID: 29069415)
1. Serotype-Specific Correlates of Protection for Pneumococcal Carriage: An Analysis of Immunity in 19 Countries.
Voysey M; Fanshawe TR; Kelly DF; O'Brien KL; Kandasamy R; Shrestha S; Thorson S; Hinds J; Pollard AJ
Clin Infect Dis; 2018 Mar; 66(6):913-920. PubMed ID: 29069415
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.
Ojal J; Hammitt LL; Gaitho J; Scott JAG; Goldblatt D
Vaccine; 2017 Aug; 35(35 Pt B):4652-4657. PubMed ID: 28739116
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.
Akinsola AK; Ota MO; Enwere GC; Okoko BJ; Zaman SM; Saaka M; Nsekpong ED; Odutola AA; Greenwood BM; Cutts FT; Adegbola RA
PLoS One; 2012; 7(2):e31050. PubMed ID: 22363544
[TBL] [Abstract][Full Text] [Related]
4. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
Dagan R; Givon-Lavi N; Porat N; Greenberg D
Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
[TBL] [Abstract][Full Text] [Related]
5. Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers.
Gurung M; Bijukchhe SM; Hariri P; Voysey M; Kandasamy R; Thorson S; Maskey P; Pandit R; Shrestha B; Gautam MC; Maharjan M; Lama L; Acharya B; Basi R; K C M; O'Reilly P; Shrestha S; Ansari I; Shah GP; Kelly S; O'Brien KL; Goldblatt D; Kelly DF; Murdoch DR; Pollard AJ; Shrestha S
Pediatr Infect Dis J; 2021 Oct; 40(10):937-943. PubMed ID: 34292271
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH
Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial.
Kandasamy R; Gurung M; Thorson S; Yu LM; Galal U; Voysey M; Kelly S; Wahl B; Berbers G; Finnegan K; Ansari I; Paudel K; Murdoch DR; O'Brien KL; Kelly DF; Goldblatt D; Shrestha S; Pollard AJ
Lancet Infect Dis; 2019 Feb; 19(2):156-164. PubMed ID: 30635252
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-regression Model.
Le Polain De Waroux O; Flasche S; Prieto-Merino D; Goldblatt D; Edmunds WJ
Pediatr Infect Dis J; 2015 Aug; 34(8):858-64. PubMed ID: 26075814
[TBL] [Abstract][Full Text] [Related]
9. Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration.
Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gruber WC; Scott DA
Vaccine; 2016 Aug; 34(36):4313-20. PubMed ID: 27422342
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?
Lindstrand A; Kalyango J; Alfvén T; Darenberg J; Kadobera D; Bwanga F; Peterson S; Henriques-Normark B; Källander K
PLoS One; 2016; 11(11):e0166018. PubMed ID: 27829063
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027
[TBL] [Abstract][Full Text] [Related]
12. The rise and fall of pneumococcal serotypes carried in the PCV era.
Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
[TBL] [Abstract][Full Text] [Related]
13. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.
Dagan R
Expert Rev Vaccines; 2019 Jun; 18(6):641-661. PubMed ID: 31230486
[No Abstract] [Full Text] [Related]
14. A toddler PCV booster dose following 3 infancy priming doses increases circulating serotype-specific IGG levels but does not increase protection against carriage.
Dagan R; Ben-Shimol S; Simell B; Greenberg D; Porat N; Käyhty H; Givon-Lavi N
Vaccine; 2018 May; 36(20):2774-2782. PubMed ID: 29655626
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
[TBL] [Abstract][Full Text] [Related]
16. Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization.
Madhi SA; Violari A; Klugman KP; Lin G; McIntyre JA; von Gottberg A; Jean-Philippe P; Cotton MF; Adrian P;
Vaccine; 2011 Sep; 29(40):6994-7001. PubMed ID: 21787822
[TBL] [Abstract][Full Text] [Related]
17. Serotype-specific immune responses to pneumococcal conjugate vaccine among children are significantly correlated by individual: Analysis of randomized controlled trial data.
Lipsitch M; Li LM; Patterson S; Trammel J; Juergens C; Gruber WC; Scott DA; Dagan R
Vaccine; 2018 Jan; 36(4):473-478. PubMed ID: 29248266
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study.
Sutcliffe CG; Shet A; Varghese R; Veeraraghavan B; Manoharan A; Wahl B; Chandy S; Sternal J; Khan R; Singh RK; Santosham M; Arora NK
BMC Infect Dis; 2019 Jul; 19(1):605. PubMed ID: 31291902
[TBL] [Abstract][Full Text] [Related]
19. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.
McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC
Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405
[TBL] [Abstract][Full Text] [Related]
20. Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.
Prins-van Ginkel AC; Berbers GA; Grundeken LH; Tcherniaeva I; Wittenberns JI; Elberse K; Mollema L; de Melker HE; Knol MJ
PLoS One; 2016; 11(1):e0147437. PubMed ID: 26796783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
